BBR Partners’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-60,000
Closed -$69K 252
2024
Q3
$69K Hold
60,000
0.01% 237
2024
Q2
$66K Hold
60,000
0.01% 213
2024
Q1
$74.4K Buy
+60,000
New +$74.4K 0.01% 249